Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins
The emergence and spread of new HIV-1 variants pose a challenge for the effectiveness of antiretrovirals (ARV) targeting Pol proteins. During viral evolution, non-synonymous mutations have fixed along the viral genome, leading to amino acid (aa) changes that can be variant-specific (V-markers). Thos...
Main Authors: | Paloma Troyano-Hernáez, Roberto Reinosa, Africa Holguín |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.866705/full |
Similar Items
-
<i>Cis</i>-Allosteric Regulation of HIV-1 Reverse Transcriptase by Integrase
by: Takao Masuda, et al.
Published: (2022-12-01) -
HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants
by: Ana Valadés-Alcaraz, et al.
Published: (2022-05-01) -
Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
by: Bluma G. Brenner, et al.
Published: (2010-11-01) -
Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
by: Yi-Ru Lin, et al.
Published: (2022-04-01) -
HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors
by: Abid Qureshi, et al.
Published: (2018-03-01)